Neuland Laboratories Limited has informed the Exchange regarding ‘We refer to our letter dated August 14, 2026 regarding the US FDA inspection conducted at our Unit 3 manufacturing facility and would like to inform that the US FDA has issued an EIR against the inspection conducted from August 10, 2026 to August 14, 2026The US FDA has concluded that this inspection is closed|SUBJECT: Updates
Source link